Blood filter to remove drugs in overdoses
This trial tests a blood-filtering device (hemadsorption) to help remove drugs from the body faster in people who are in the ICU after an overdose of certain sedatives or antidepressants, especially if they have liver or kidney problems.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 or older
- You are in the intensive care unit (ICU) after an overdose
- Your consciousness is very low or you needed a reversing medicine 8 hours after arriving at the hospital
- You overdosed on a benzodiazepine (like Valium) or a tricyclic antidepressant (like amitriptyline)
- You have severe liver or kidney disease that makes it harder for your body to clear the drug
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a device called CytoSorb that filters the blood to reduce inflammation in patients with sudden worsening of chronic liver disease. It may help support organ function and recovery.
This study tests when and how much fluid should be removed from patients in the intensive care unit (ICU) who need help getting rid of extra fluid. It uses medicines called diuretics or a machine that filters the blood (ultrafiltration) to find the best approach.
This trial is testing a special blood filter (oXiris) to see if it helps remove harmful substances from the blood of people in the intensive care unit with shock and kidney failure. It may help improve blood pressure and reduce the need for strong medicines.
This trial tests a specific type of blood-filter treatment in critically ill ICU patients who have acute kidney injury and/or failure of other organs. It aims to see whether these filters can improve care by supporting kidney function and/or calming harmful inflammation.
This trial tests a special blood filter called Oxiris that may help remove toxins and inflammation from the blood in patients with septic shock. It aims to see if this treatment can improve outcomes for people who need kidney replacement therapy.
This study tests a special filter (HA380 column) used during dialysis or ECMO to remove harmful substances from the blood. It is for critically ill patients with severe infection, injury, or breathing problems who also need kidney or lung support.
Hear when a new Intoxication by Drug trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.